Comparison between Gensol Engineering IPO and Par Drugs IPO.
Gensol Engineering IPO is a SME Fixed Price IPO proposed to list at BSE SME while Par Drugs IPO is a SME Fixed Price proposed to list at NSE SME.
| Gensol Engineering IPO | Par Drugs IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Fixed Price |
| Listing At | BSE SME | NSE SME |
| Lead Managers | Pantomath Capital Advisors Pvt.Ltd. | Pantomath Capital Advisors Pvt.Ltd. |
| Registrar | MUFG Intime India Pvt.Ltd. | MUFG Intime India Pvt.Ltd. |
| Market Maker | Gretex Share Broking Pvt.Ltd. | Pantomath Stock Brokers Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Gensol Engineering IPO is up to ₹17.02 Cr whereas the issue size of the Par Drugs IPO is up to ₹8.10 Cr. The final issue price of Gensol Engineering IPO is ₹83.00 per share and of Par Drugs IPO is ₹51.00 per share.
| Gensol Engineering IPO | Par Drugs IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹81.00 per share | |
| Issue Price (Upper) | ₹83.00 per share | |
| Issue Price (Final) | ₹83.00 per share | ₹51.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹0.00 per share | |
| Market Lot Size | 1600 shares | 2000 shares |
| Fresh Issue Size | 20,51,200 shares | 15,88,000 shares |
| Fresh Issue Size (Amount) | up to ₹17.02 Cr | up to ₹8.10 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 20,51,200 shares | 15,88,000 shares |
| Issue Size Total (Amount) | up to ₹17.02 Cr | up to ₹8.10 Cr |
Gensol Engineering IPO opens on Sep 30, 2019, while Par Drugs IPO opens on May 03, 2019. The closing date of Gensol Engineering IPO and Par Drugs IPO is Oct 04, 2019, and May 08, 2019, respectively.
| Gensol Engineering IPO | Par Drugs IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Sep 30, 2019 | May 03, 2019 |
| Issue Close | Oct 04, 2019 | May 08, 2019 |
| Basis Of Allotment (Tentative) | Oct 10, 2019 | May 13, 2019 |
| Initiation of Refunds (Tentative) | Oct 11, 2019 | May 14, 2019 |
| Credit of Share (Tentative) | Oct 14, 2019 | May 15, 2019 |
| Listing date (Tentative) | Oct 15, 2019 | May 16, 2019 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Gensol Engineering IPO P/E ratio is , as compared to Par Drugs IPO P/E ratio of .
| Gensol Engineering IPO | Par Drugs IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 96 | 99.55 | ||||
| Promoter Shareholding (Post-Issue) | 70.72 | 72.82 | ||||
| P/E Ratio | ||||||
| Market Cap | ₹68.08 Cr. | ₹31.38 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW |
In the Gensol Engineering IPO Retail Individual Investors (RII) are offered 10,25,600 shares while in Par Drugs IPO retail investors are offered 10,25,600 shares. Qualified Institutional Buyers (QIB) are offered in Gensol Engineering IPO and in Par Drugs IPO.
| Gensol Engineering IPO | Par Drugs IPO | |
|---|---|---|
| Anchor Investor Reservation | ||
| Market Maker Reservation | 1,08,800 shares | 84,000 shares |
| QIB | ||
| NII | 10,25,600 shares | 7,78,000 shares |
| RII | 10,25,600 shares | 7,80,000 shares |
| Employee | 30,000 shares | |
| Others | ||
| Total | 20,51,200 shares | 15,88,000 shares |
Gensol Engineering IPO subscribed 1.32x in total, whereas Par Drugs IPO subscribed 5.64x.
| Gensol Engineering IPO | Par Drugs IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | 2.27x | 3.48x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 0.37x | 7.97x |
| Employee (times) | 1.00x | |
| Other (times) | ||
| Total (times) | 1.32x | 5.64x |
